ERBB2 c.2264T>C ;(p.L755S)

Variant ID: 17-37880220-T-C

NM_004448.2(ERBB2):c.2264T>C;(p.L755S)

This variant was identified in 327 publications

View GRCh38 version.




Publications:


Estrogen/HER2 receptor crosstalk in breast cancer: combination therapies to improve outcomes for patients with hormone receptor-positive/HER2-positive breast cancer.

Npj Breast Cancer
Pegram, Mark M; Jackisch, Christian C; Johnston, Stephen R D SRD
Publication Date: 2023-05-31

Variant appearance in text: ERBB2: L755S
PubMed Link: 37258523
Variant Present in the following documents:
  • Main text
  • 41523_2023_Article_533.pdf
View BVdb publication page



Ado-tratuzumab emtansine beyond breast cancer: therapeutic role of targeting other HER2-positive cancers.

Frontiers In Molecular Biosciences
Zheng, Yang Y; Zou, Jiayu J; Sun, Chen C; Peng, Fu F; Peng, Cheng C
Publication Date: 2023

Variant appearance in text: HER2: L755S
PubMed Link: 37251081
Variant Present in the following documents:
  • Main text
  • fmolb-10-1165781.pdf
View BVdb publication page



Therapies beyond Physiological Barriers and Drug Resistance: A Pilot Study and Review of the Literature Investigating If Intrathecal Trastuzumab and New Treatment Options Can Improve Oncologic Outcomes in Leptomeningeal Metastases from HER2-Positive Breast Cancer.

Cancers
Trifănescu, Oana Gabriela OG; Mitrea, Dan D; Galeș, Laurenția Nicoleta LN; Ciornei, Ana A; Păun, Mihai-Andrei MA; Butnariu, Ioana I; Trifănescu, Raluca Alexandra RA; Motaș, Natalia N; Toma, Radu Valeriu RV; Bîlteanu, Liviu L; Gherghe, Mirela M; Anghel, Rodica Maricela RM
Publication Date: 2023-04-27

Variant appearance in text: HER2: L755S
PubMed Link: 37173973
Variant Present in the following documents:
  • Main text
  • cancers-15-02508.pdf
View BVdb publication page



Pan-cancer whole-genome comparison of primary and metastatic solid tumours.

Nature
Martínez-Jiménez, Francisco F; Movasati, Ali A; Brunner, Sascha Remy SR; Nguyen, Luan L; Priestley, Peter P; Cuppen, Edwin E; Van Hoeck, Arne A
Publication Date: 2023-05-10

Variant appearance in text: ERBB2: L755S
PubMed Link: 37165194
Variant Present in the following documents:
  • 41586_2023_6054_MOESM1_ESM.pdf
  • 41586_2023_6054_MOESM12_ESM.xlsx, sheet 5
  • 41586_2023_6054_MOESM3_ESM.pdf
View BVdb publication page



Resistance to anti-HER2 therapy associated with the TSC2 nonsynonymous variant c.4349 C > G (p.Pro1450Arg) is reversed by CDK4/6 inhibitor in HER2-positive breast cancer.

Npj Breast Cancer
Yang, Ziyan Z; Feng, Jianguo J; Jing, Ji J; Huang, Yuan Y; Ye, Wei-Wu WW; Lei, Lei L; Wang, Xiao-Jia XJ; Cao, Wen-Ming WM
Publication Date: 2023-05-09

Variant appearance in text: HER2: L755S
PubMed Link: 37160904
Variant Present in the following documents:
  • 41523_2023_Article_542.pdf
View BVdb publication page



Workflow enabling deepscale immunopeptidome, proteome, ubiquitylome, phosphoproteome, and acetylome analyses of sample-limited tissues.

Nature Communications
Abelin, Jennifer G JG; Bergstrom, Erik J EJ; Rivera, Keith D KD; Taylor, Hannah B HB; Klaeger, Susan S; Xu, Charles C; Verzani, Eva K EK; Jackson White, C C; Woldemichael, Hilina B HB; Virshup, Maya M; Olive, Meagan E ME; Maynard, Myranda M; Vartany, Stephanie A SA; Allen, Joseph D JD; Phulphagar, Kshiti K; Harry Kane, M M; Rachimi, Suzanna S; Mani, D R DR; Gillette, Michael A MA; Satpathy, Shankha S; Clauser, Karl R KR; Udeshi, Namrata D ND; Carr, Steven A SA
Publication Date: 2023-04-03

Variant appearance in text: ERBB2: L755S
PubMed Link: 37012232
Variant Present in the following documents:
  • 41467_2023_37547_MOESM10_ESM.xlsx, sheet 4
  • 41467_2023_37547_MOESM10_ESM.xlsx, sheet 3
  • 41467_2023_37547_MOESM10_ESM.xlsx, sheet 2
  • 41467_2023_37547_MOESM12_ESM.xlsx, sheet 3
  • 41467_2023_37547_MOESM12_ESM.xlsx, sheet 2
View BVdb publication page



Subtyping-based platform guides precision medicine for heavily pretreated metastatic triple-negative breast cancer: The FUTURE phase II umbrella clinical trial.

Cell Research
Liu, Yin Y; Zhu, Xiu-Zhi XZ; Xiao, Yi Y; Wu, Song-Yang SY; Zuo, Wen-Jia WJ; Yu, Qiang Q; Cao, A-Yong AY; Li, Jun-Jie JJ; Yu, Ke-Da KD; Liu, Guang-Yu GY; Wu, Jiong J; Sun, Tao T; Cui, Jiu-Wei JW; Lv, Zheng Z; Li, Hui-Ping HP; Zhu, Xiao-Yu XY; Jiang, Yi-Zhou YZ; Wang, Zhong-Hua ZH; Shao, Zhi-Ming ZM
Publication Date: 2023-03-27

Variant appearance in text: ERBB2: L755S
PubMed Link: 36973538
Variant Present in the following documents:
  • 41422_2023_795_MOESM1_ESM.pdf
View BVdb publication page



The role of irreversible pan-HER tyrosine kinase inhibitors in the treatment of HER2-Positive metastatic breast cancer.

Frontiers In Pharmacology
Wu, Zihong Z; Wang, Jiamei J; You, Fengming F; Li, Xueke X; Xiao, Chong C
Publication Date: 2023

Variant appearance in text: HER2: L755S
PubMed Link: 36937848
Variant Present in the following documents:
  • Main text
  • fphar-14-1142087.pdf
View BVdb publication page



A generalizable machine learning framework for classifying DNA repair defects using ctDNA exomes.

Npj Precision Oncology
Ritch, Elie J EJ; Herberts, Cameron C; Warner, Evan W EW; Ng, Sarah W S SWS; Kwan, Edmond M EM; Bacon, Jack V W JVW; Bernales, Cecily Q CQ; Schönlau, Elena E; Fonseca, Nicolette M NM; Giri, Veda N VN; Maurice-Dror, Corinne C; Vandekerkhove, Gillian G; Jones, Steven J M SJM; Chi, Kim N KN; Wyatt, Alexander W AW
Publication Date: 2023-03-13

Variant appearance in text: ERBB2: L755S
PubMed Link: 36914848
Variant Present in the following documents:
  • 41698_2023_366_MOESM2_ESM.xlsx, sheet 4
View BVdb publication page



Unlocking the Resistance to Anti-HER2 Treatments in Breast Cancer: The Issue of HER2 Spatial Distribution.

Cancers
Giugliano, Federica F; Carnevale Schianca, Ambra A; Corti, Chiara C; Ivanova, Mariia M; Bianco, Nadia N; Dellapasqua, Silvia S; Criscitiello, Carmen C; Fusco, Nicola N; Curigliano, Giuseppe G; Munzone, Elisabetta E
Publication Date: 2023-02-22

Variant appearance in text: HER2: L755S
PubMed Link: 36900178
Variant Present in the following documents:
  • Main text
  • cancers-15-01385.pdf
View BVdb publication page



Comparative analysis of EpCAM high-expressing and low-expressing circulating tumour cells with regard to their clonal relationship and clinical value.

British Journal Of Cancer
Franken, André A; Kraemer, Annika A; Sicking, Alicia A; Watolla, Meike M; Rivandi, Mahdi M; Yang, Liwen L; Warfsmann, Jens J; Polzer, Bernhard M BM; Friedl, Thomas W P TWP; Meier-Stiegen, Franziska F; Stoecklein, Nikolas H NH; Dayan, Davut D; Riethdorf, Sabine S; Mueller, Volkmar V; Pantel, Klaus K; Koch, André A; Hartkopf, Andreas D AD; Krawczyk, Natalia N; Ruckhaeberle, Eugen E; Niederacher, Dieter D; Fehm, Tanja T; Neubauer, Hans H
Publication Date: 2023-02-23

Variant appearance in text: ERBB2: L755S
PubMed Link: 36823365
Variant Present in the following documents:
  • Main text
  • 41416_2023_Article_2179.pdf
View BVdb publication page



Pan-cancer clinical impact of latent drivers from double mutations.

Communications Biology
Yavuz, Bengi Ruken BR; Tsai, Chung-Jung CJ; Nussinov, Ruth R; Tuncbag, Nurcan N
Publication Date: 2023-02-20

Variant appearance in text: ERBB2: L755S
PubMed Link: 36808143
Variant Present in the following documents:
  • 42003_2023_4519_MOESM3_ESM.xlsx, sheet 3
View BVdb publication page



Antitumour activity of neratinib in patients with HER2-mutant advanced biliary tract cancers.

Nature Communications
Harding, James J JJ; Piha-Paul, Sarina A SA; Shah, Ronak H RH; Murphy, Jessica J JJ; Cleary, James M JM; Shapiro, Geoffrey I GI; Quinn, David I DI; Braña, Irene I; Moreno, Victor V; Borad, Mitesh M; Loi, Sherene S; Spanggaard, Iben I; Park, Haeseong H; Ford, James M JM; Arnedos, Mónica M; Stemmer, Salomon M SM; de la Fouchardiere, Christelle C; Fountzilas, Christos C; Zhang, Jie J; DiPrimeo, Daniel D; Savin, Casey C; Duygu Selcuklu, S S; Berger, Michael F MF; Eli, Lisa D LD; Meric-Bernstam, Funda F; Jhaveri, Komal K; Solit, David B DB; Abou-Alfa, Ghassan K GK
Publication Date: 2023-02-06

Variant appearance in text: ERBB2: L755S
PubMed Link: 36746967
Variant Present in the following documents:
  • 41467_2023_36399_MOESM1_ESM.pdf
  • 41467_2023_Article_36399.pdf
  • 41467_2023_36399_MOESM3_ESM.xlsx, sheet 5
View BVdb publication page



Investigation of the prevalence and clinical implications of ERBB2 exon 16 skipping mutations in Chinese pan-cancer patients.

Frontiers In Oncology
Shang, Yanhong Y; Mo, Jianming J; Huo, Ran R; Li, Xiaofang X; Fang, Guotao G; Wei, Zichun Z; Gu, Guomin G; Zhu, Xiaodan X; Zhang, Chan C; Liu, Chunling C; Yan, Dong D
Publication Date: 2022

Variant appearance in text: ERBB2: L755S
PubMed Link: 36686783
Variant Present in the following documents:
  • Main text
  • fonc-12-1064598.pdf
View BVdb publication page



Improving HER2 testing reproducibility in HER2-low breast cancer.

Cancer Drug Resistance (Alhambra, Calif.)
Sajjadi, Elham E; Venetis, Konstantinos K; Ivanova, Mariia M; Fusco, Nicola N
Publication Date: 2022

Variant appearance in text: HER2: L755S
PubMed Link: 36627898
Variant Present in the following documents:
  • cdr-5-4-882.pdf
View BVdb publication page



Tumor genomic profiling and personalized tracking of circulating tumor DNA in Vietnamese colorectal cancer patients.

Frontiers In Oncology
Nguyen, Huu Thinh HT; Nguyen, Trieu Vu TV; Nguyen Hoang, Van-Anh VA; Tran, Duc Huy DH; Le Trinh, Ngoc An NA; Le, Minh Triet MT; Nguyen Tran, Tuan-Anh TA; Pham, Thanh Huyen TH; Dinh, Thi Cuc TC; Nguyen, Tien Sy TS; Nguyen The, Ky Cuong KC; Mai, Hoa H; Chu, Minh Tuan MT; Pham, Dinh Hoang DH; Nguyen, Xuan Chi XC; Ngo Ha, Thien My TM; Nguyen, Duy Sinh DS; Nguyen, Du Quyen DQ; Lu, Y-Thanh YT; Do Thi, Thanh Thuy TT; Truong, Dinh Kiet DK; Nguyen, Quynh Tho QT; Nguyen, Hoai-Nghia HN; Giang, Hoa H; Tu, Lan N LN
Publication Date: 2022

Variant appearance in text: ERBB2: L755S
PubMed Link: 36578946
Variant Present in the following documents:
  • DataSheet_2.xlsx, sheet 1
View BVdb publication page



Clinical updates on tyrosine kinase inhibitors in HER2-positive breast cancer.

Frontiers In Pharmacology
Singh, Desh Deepak DD; Lee, Hae-Jeung HJ; Yadav, Dharmendra Kumar DK
Publication Date: 2022

Variant appearance in text: HER2: L755S
PubMed Link: 36578543
Variant Present in the following documents:
  • Main text
View BVdb publication page



The Role of Tumor-Associated Antigen HER2/neu in Tumor Development and the Different Approaches for Using It in Treatment: Many Choices and Future Directions.

Cancers
Alrhmoun, Saleh S; Sennikov, Sergey S
Publication Date: 2022-12-14

Variant appearance in text: HER2: L755S
PubMed Link: 36551661
Variant Present in the following documents:
  • cancers-14-06173.pdf
View BVdb publication page



Genetic landscape and personalized tracking of tumor mutations in Vietnamese women with breast cancer.

Molecular Oncology
Nguyen Hoang, Van-Anh VA; Nguyen, Sao Trung ST; Nguyen, Trieu Vu TV; Pham, Thanh Huyen TH; Doan, Phuoc Loc PL; Nguyen Thi, Ngoc Thanh NT; Nguyen, Minh Long ML; Dinh, Thi Cuc TC; Pham, Dinh Hoang DH; Nguyen, Ngoc Mai NM; Nguyen, Duy Sinh DS; Nguyen, Du Quyen DQ; Lu, Y-Thanh YT; Do, Thanh Thuy Thi TTT; Truong, Dinh Kiet DK; Phan, Minh-Duy MD; Nguyen, Hoai-Nghia HN; Giang, Hoa H; Tu, Lan N LN
Publication Date: 2022-12-10

Variant appearance in text: ERBB2: L755S
PubMed Link: 36495126
Variant Present in the following documents:
  • MOL2-17-598-s002.xlsx, sheet 2
  • MOL2-17-598-s002.xlsx, sheet 1
View BVdb publication page



Targeting the EGF receptor family in non-small cell lung cancer-increased complexity and future perspectives.

Cancer Biology & Medicine
Boch, Tobias T; Köhler, Jens J; Janning, Melanie M; Loges, Sonja S
Publication Date: 2022-12-05

Variant appearance in text: HER2: L755S
PubMed Link: 36476337
Variant Present in the following documents:
  • Main text
  • cbm-19-1543.pdf
View BVdb publication page



Tissue and liquid biopsy profiling reveal convergent tumor evolution and therapy evasion in breast cancer.

Nature Communications
Sivakumar, Smruthy S; Jin, Dexter X DX; Tukachinsky, Hanna H; Murugesan, Karthikeyan K; McGregor, Kimberly K; Danziger, Natalie N; Pavlick, Dean D; Gjoerup, Ole O; Ross, Jeffrey S JS; Harmon, Robert R; Chung, Jon J; Decker, Brennan B; Dennis, Lucas L; Frampton, Garrett M GM; Molinero, Luciana L; Oesterreich, Steffi S; Venstrom, Jeffrey M JM; Oxnard, Geoffrey R GR; Hegde, Priti S PS; Sokol, Ethan S ES
Publication Date: 2022-12-05

Variant appearance in text: ERBB2: L755S
PubMed Link: 36470901
Variant Present in the following documents:
  • Main text
  • 41467_2022_35245_MOESM4_ESM.xlsx, sheet 17
  • 41467_2022_Article_35245.pdf
View BVdb publication page



Concordance Between Recommendations From Multidisciplinary Molecular Tumor Boards and Central Consensus for Cancer Treatment in Japan.

Jama Network Open
Naito, Yoichi Y; Sunami, Kuniko K; Kage, Hidenori H; Komine, Keigo K; Amano, Toraji T; Imai, Mitsuho M; Koyama, Takafumi T; Ennishi, Daisuke D; Kanai, Masashi M; Kenmotsu, Hirotsugu H; Maeda, Takahiro T; Morita, Sachi S; Sakai, Daisuke D; Watanabe, Kousuke K; Shirota, Hidekazu H; Kinoshita, Ichiro I; Yoshioka, Masashiro M; Mamesaya, Nobuaki N; Ito, Mamoru M; Kohsaka, Shinji S; Saigusa, Yusuke Y; Yamamoto, Kouji K; Hirata, Makoto M; Tsuchihara, Katsuya K; Yoshino, Takayuki T
Publication Date: 2022-12-01

Variant appearance in text: ERBB2: L755S
PubMed Link: 36469316
Variant Present in the following documents:
  • Main text
View BVdb publication page



Polyclonal antibody-induced downregulation of HER1/EGFR and HER2 surpasses the effect of combinations of specific registered antibodies.

Frontiers In Oncology
Bergado-Báez, Gretchen G; Gonzalez Suarez, Narjara N; García, Lisset Chao LC; Pérez-Martínez, Dayana D; Hernández-Fernández, Diana Rosa DR; Fundora-Barrios, Talia T; Rodríguez-Álvarez, Antonio A; Díaz-Ordaz, Geidy Diana GD; Lindzen, Moshit M; Yarden, Yosef Y; Sánchez-Ramírez, Belinda B
Publication Date: 2022

Variant appearance in text: HER2: L755S
PubMed Link: 36408164
Variant Present in the following documents:
  • Main text
  • fonc-12-951267.pdf
View BVdb publication page



Somatic mutation distribution across tumour cohorts provides a signal for positive selection in cancer.

Nature Communications
Boström, Martin M; Larsson, Erik E
Publication Date: 2022-11-17

Variant appearance in text: ERBB2: L755S
PubMed Link: 36396655
Variant Present in the following documents:
  • 41467_2022_34746_MOESM10_ESM.xlsx, sheet 1
View BVdb publication page



Clinical implication of genetic composition and molecular mechanism on treatment strategies of HER2-positive breast cancers.

Frontiers In Oncology
Chow, Christopher Y C CYC; Lie, Erich Ferdiansyah EF; Wu, Cheng-Hsun CH; Chow, Louis W C LWC
Publication Date: 2022

Variant appearance in text: HER2: L755S
PubMed Link: 36387174
Variant Present in the following documents:
  • Main text
  • fonc-12-964824.pdf
View BVdb publication page



Targeting HER2-positive breast cancer: advances and future directions.

Nature Reviews. Drug Discovery
Swain, Sandra M SM; Shastry, Mythili M; Hamilton, Erika E
Publication Date: 2022-11-07

Variant appearance in text: HER2: L755S
PubMed Link: 36344672
Variant Present in the following documents:
  • Main text
  • 41573_2022_Article_579.pdf
View BVdb publication page



Genomic landscape, immune characteristics and prognostic mutation signature of cervical cancer in China.

Bmc Medical Genomics
Liu, Jing J; Li, Zirong Z; Lu, Ting T; Pan, Junping J; Li, Li L; Song, Yanwen Y; Hu, Dan D; Zhuo, Yanhong Y; Chen, Ying Y; Xu, Qin Q
Publication Date: 2022-11-04

Variant appearance in text: ERBB2: 2264T>C; L755S
PubMed Link: 36333792
Variant Present in the following documents:
  • 12920_2022_1376_MOESM1_ESM.xlsx, sheet 1
View BVdb publication page



Landscape of Genomic Alterations and PD-L1 Expression in Early-Stage Non-Small-Cell Lung Cancer (NSCLC)-A Single Center, Retrospective Observational Study.

International Journal Of Molecular Sciences
Stephan-Falkenau, Susann S; Streubel, Anna A; Mairinger, Thomas T; Kollmeier, Jens J; Misch, Daniel D; Thiel, Sebastian S; Bauer, Torsten T; Pfannschmidt, Joachim J; Hollmann, Manuel M; Wessolly, Michael M; Blum, Torsten Gerriet TG
Publication Date: 2022-10-19

Variant appearance in text: ERBB2: L755S
PubMed Link: 36293366
Variant Present in the following documents:
  • Main text
  • ijms-23-12511.pdf
View BVdb publication page



Molecular targeted therapy for anticancer treatment.

Experimental & Molecular Medicine
Min, Hye-Young HY; Lee, Ho-Young HY
Publication Date: 2022-10

Variant appearance in text: HER2: L755S
PubMed Link: 36224343
Variant Present in the following documents:
  • Main text
  • 12276_2022_Article_864.pdf
View BVdb publication page



The mutational landscape of cancer's vulnerability to ionizing radiation.

Clinical Cancer Research : An Official Journal Of The American Association For Cancer Research
Gopal, Priyanka P; Yard, Brian D BD; Petty, Aaron A; Lal, Jessica C JC; Bera, Titas K TK; Hoang, Trung Q TQ; Buhimschi, Alexandru B AB; Abazeed, Mohamed E ME
Publication Date: 2022-10-12

Variant appearance in text: ERBB2: L755S
PubMed Link: 36222846
Variant Present in the following documents:
  • ccr-22-1914_supplementary_data_2_suppds2.xlsx, sheet 1
  • ccr-22-1914_supplementary_data_3_suppds3.xlsx, sheet 1
View BVdb publication page



Prevalence of Molecular Alterations in a Swiss Cohort of 512 Colorectal Carcinoma Patients by Targeted Next-Generation Sequencing Analysis in Routine Diagnostics.

Pathobiology : Journal Of Immunopathology, Molecular And Cellular Biology
Haefliger, Simon S; Marston, Katharina K; Alborelli, Ilaria I; Stauffer, Edouard-Jean EJ; Gugger, Mathias M; Jermann, Philip M PM; Hoeller, Sylvia S; Tornillo, Luigi L; Terracciano, Luigi M LM; Bihl, Michel M; Matter, Matthias S MS
Publication Date: 2022-10-06

Variant appearance in text: ERBB2: L755S
PubMed Link: 36202073
Variant Present in the following documents:
  • pat-0090-0166-s01.pdf
View BVdb publication page



High p16 expression and heterozygous RB1 loss are biomarkers for CDK4/6 inhibitor resistance in ER+ breast cancer.

Nature Communications
Palafox, Marta M; Monserrat, Laia L; Bellet, Meritxell M; Villacampa, Guillermo G; Gonzalez-Perez, Abel A; Oliveira, Mafalda M; Brasó-Maristany, Fara F; Ibrahimi, Nusaibah N; Kannan, Srinivasaraghavan S; Mina, Leonardo L; Herrera-Abreu, Maria Teresa MT; Òdena, Andreu A; Sánchez-Guixé, Mònica M; Capelán, Marta M; Azaro, Analía A; Bruna, Alejandra A; Rodríguez, Olga O; Guzmán, Marta M; Grueso, Judit J; Viaplana, Cristina C; Hernández, Javier J; Su, Faye F; Lin, Kui K; Clarke, Robert B RB; Caldas, Carlos C; Arribas, Joaquín J; Michiels, Stefan S; García-Sanz, Alicia A; Turner, Nicholas C NC; Prat, Aleix A; Nuciforo, Paolo P; Dienstmann, Rodrigo R; Verma, Chandra S CS; Lopez-Bigas, Nuria N; Scaltriti, Maurizio M; Arnedos, Monica M; Saura, Cristina C; Serra, Violeta V
Publication Date: 2022-09-07

Variant appearance in text: ERBB2: 2264T>C; L755S
PubMed Link: 36071033
Variant Present in the following documents:
  • 41467_2022_32828_MOESM4_ESM.xlsx, sheet 3
View BVdb publication page



The circulating tumor DNA (ctDNA) alteration level predicts therapeutic response in metastatic breast cancer: Novel prognostic indexes based on ctDNA.

Breast (Edinburgh, Scotland)
Liu, Binliang B; Hu, Zheyu Z; Ran, Jialu J; Xie, Ning N; Tian, Can C; Tang, Yu Y; Ouyang, Quchang Q
Publication Date: 2022-10

Variant appearance in text: ERBB2: L755S
PubMed Link: 35926241
Variant Present in the following documents:
  • mmc1.xlsx, sheet 1
View BVdb publication page



ERBB2 mutation is associated with sustained tumor cell proliferation after short-term preoperative endocrine therapy in early lobular breast cancer.

Modern Pathology : An Official Journal Of The United States And Canadian Academy Of Pathology, Inc
Grote, Isabel I; Bartels, Stephan S; Christgen, Henriette H; Radner, Martin M; Gronewold, Malte M; Kandt, Leonie L; Raap, Mieke M; Lehmann, Ulrich U; Gluz, Oleg O; Graeser, Monika M; Kuemmel, Sherko S; Nitz, Ulrike U; Harbeck, Nadia N; Kreipe, Hans H; Christgen, Matthias M
Publication Date: 2022-12

Variant appearance in text: ERBB2: L755S
PubMed Link: 35842479
Variant Present in the following documents:
  • Main text
  • 41379_2022_1130_MOESM1_ESM.pdf
  • 41379_2022_Article_1130.pdf
View BVdb publication page



Scalable multiplex co-fractionation/mass spectrometry platform for accelerated protein interactome discovery.

Nature Communications
Havugimana, Pierre C PC; Goel, Raghuveera Kumar RK; Phanse, Sadhna S; Youssef, Ahmed A; Padhorny, Dzmitry D; Kotelnikov, Sergei S; Kozakov, Dima D; Emili, Andrew A
Publication Date: 2022-07-13

Variant appearance in text: ERBB2: 2264T>C; Leu755Ser; rs121913470
PubMed Link: 35831314
Variant Present in the following documents:
  • 41467_2022_31809_MOESM8_ESM.xlsx, sheet 3
View BVdb publication page



Cross-Resistance Among Sequential Cancer Therapeutics: An Emerging Issue.

Frontiers In Oncology
Loria, Rossella R; Vici, Patrizia P; Di Lisa, Francesca Sofia FS; Soddu, Silvia S; Maugeri-Saccà, Marcello M; Bon, Giulia G
Publication Date: 2022

Variant appearance in text: HER2: L755S
PubMed Link: 35814399
Variant Present in the following documents:
  • Main text
  • fonc-12-877380.pdf
View BVdb publication page



Poziotinib Inhibits HER2-Mutant-Driven Therapeutic Resistance and Multiorgan Metastasis in Breast Cancer.

Cancer Research
Kalra, Rashi R; Chen, Ching Hui CH; Wang, Junkai J; Salam, Ahmad Bin AB; Dobrolecki, Lacey E LE; Lewis, Alaina A; Sallas, Christina C; Yates, Clayton C CC; Gutierrez, Carolina C; Karanam, Balasubramanyam B; Anurag, Meenakshi M; Lim, Bora B; Ellis, Matthew J MJ; Kavuri, Shyam M SM
Publication Date: 2022-08-16

Variant appearance in text: HER2: L755S
PubMed Link: 35736563
Variant Present in the following documents:
  • can-21-3106_supplementary_data_suppst1.xlsx, sheet 2
View BVdb publication page



Construction and validation of an immunoediting-based optimized neoantigen load (ioTNL) model to predict the response and prognosis of immune checkpoint therapy in various cancers.

Aging
Su, Xiaofan X; Jin, Haoxuan H; Wang, Jiaqian J; Lu, Huiping H; Gu, Tiantian T; Gao, Zhibo Z; Li, Manxiang M
Publication Date: 2022-05-25

Variant appearance in text: ERBB2: 2264T>C; L755S
PubMed Link: 35613927
Variant Present in the following documents:
  • aging-14-204101-s004.xlsx, sheet 1
View BVdb publication page



Chemoenzymatic Synthesis of Original Stilbene Dimers Possessing Wnt Inhibition Activity in Triple-Negative Breast Cancer Cells Using the Enzymatic Secretome of Botrytis cinerea Pers.

Frontiers In Chemistry
Huber, Robin R; Koval, Alexey A; Marcourt, Laurence L; Héritier, Margaux M; Schnee, Sylvain S; Michellod, Emilie E; Scapozza, Leonardo L; Katanaev, Vladimir L VL; Wolfender, Jean-Luc JL; Gindro, Katia K; Ferreira Queiroz, Emerson E
Publication Date: 2022

Variant appearance in text: HER2: L755S
PubMed Link: 35518712
Variant Present in the following documents:
  • fchem-10-881298.pdf
View BVdb publication page